Pictet Asset Management Holding Sa Alnylam Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 430,612 shares of ALNY stock, worth $108 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
430,612
Previous 664,722
35.22%
Holding current value
$108 Million
Previous $183 Million
44.58%
% of portfolio
0.11%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding ALNY
# of Institutions
667Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.16 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.19 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.39 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.75 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.1 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.8B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...